BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

5637

201686

PAR

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

PAR DRUGS AND CHEM LTD performance

Today’s low

Today’s high

₹ 97.15 ₹ 101.90
₹ 99.41

52 week low

52 week high

₹ 81.01 ₹ 348.45
₹ 99.41

Open Price

₹ 101.00

Prev. Close

₹ 102.14

Volume (Shares)

4921.00

Total traded value

₹ 4.89

Upper Circuit

₹ 107.24

Lower Circuit

₹ 97.03

info

PAR DRUGS AND CHEM LTD Share Price Update

As of the latest trading session, PAR DRUGS AND CHEM LTD share price is currently at ₹ 98.5, which is down by ₹ -3.63 from its previous closing. Today, the stock has fluctuated between ₹ 97.15 and ₹ 101.90. Over the past year, PAR DRUGS AND CHEM LTD has achieved a return of -63.11 %. In the last month alone, the return has been 14.68 %. Read More...

PAR DRUGS AND CHEM LTD fundamentals


  • Market cap (Cr)

    122.30

  • P/E Ratio (TTM)

    7.93

  • Beta

    0.85

  • Book Value / share

    78.63

  • Return on equity

    18.49%

  • EPS (TTM)

    12.54

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.58

info icon alternate text
  • Market cap (Cr)

    0.0

  • P/E Ratio (TTM)

    0.0

  • Beta

    0.0

  • Book Value / share

    0.0

  • Return on equity

    0.0%

  • EPS (TTM)

    0.0

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    0.0

info icon alternate text

PAR DRUGS AND CHEM LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 21.38
Operating Expense 20.88
Net Profit 0.58
Net Profit Margin (%) 2.71
Earnings Per Share (EPS) 0.47
EBITDA 1.69
Effective Tax Rate (%) 24.67
Particulars SEP 2024 (Values in Cr)
Revenue 34.66
Operating Expense 24.19
Net Profit 8.60
Net Profit Margin (%) 24.81
Earnings Per Share (EPS) 6.99
EBITDA 12.43
Effective Tax Rate (%) 25.15
Particulars JUN 2024 (Values in Cr)
Revenue 22.61
Operating Expense 19.29
Net Profit 2.53
Net Profit Margin (%) 11.18
Earnings Per Share (EPS) 2.06
EBITDA 4.31
Effective Tax Rate (%) 25.07
Particulars MAR 2024 (Values in Cr)
Revenue 22.82
Operating Expense 17.67
Net Profit 3.72
Net Profit Margin (%) 16.30
Earnings Per Share (EPS) 3.02
EBITDA 6.05
Effective Tax Rate (%) 27.20
Particulars DEC 2023 (Values in Cr)
Revenue 24.00
Operating Expense 19.66
Net Profit 3.42
Net Profit Margin (%) 14.24
Earnings Per Share (EPS) 2.78
EBITDA 5.46
Effective Tax Rate (%) 25.16
Particulars MAR 2024 (Values in Cr)
Revenue 95.64
Operating Expense 76.37
Net Profit 14.50
Net Profit Margin (%) 15.16
Earnings Per Share (EPS) 11.78
EBITDA 23.07
Effective Tax Rate (%) 25.71
Particulars MAR 2023 (Values in Cr)
Revenue 95.75
Operating Expense 80.89
Net Profit 11.33
Net Profit Margin (%) 11.83
Earnings Per Share (EPS) 9.21
EBITDA 18.44
Effective Tax Rate (%) 24.86
Particulars MAR 2022 (Values in Cr)
Revenue 75.07
Operating Expense 62.55
Net Profit 9.21
Net Profit Margin (%) 12.26
Earnings Per Share (EPS) 7.49
EBITDA 16.43
Effective Tax Rate (%) 27.48
Particulars MAR 2021 (Values in Cr)
Revenue 60.75
Operating Expense 48.20
Net Profit 11.61
Net Profit Margin (%) 19.11
Earnings Per Share (EPS) 18.87
EBITDA 18.19
Effective Tax Rate (%) 21.11
Particulars MAR 2020 (Values in Cr)
Revenue 55.85
Operating Expense 49.94
Net Profit 4.77
Net Profit Margin (%) 8.54
Earnings Per Share (EPS) 7.75
EBITDA 9.54
Effective Tax Rate (%) 20.53
Particulars MAR 2024 (Values in Cr)
Book Value / Share 69.59
ROE % 18.49
ROCE % 25.01
Total Debt to Total Equity 0.00
EBITDA Margin 24.11
Particulars MAR 2023 (Values in Cr)
Book Value / Share 57.90
ROE % 17.28
ROCE % 23.11
Total Debt to Total Equity 0.00
EBITDA Margin 19.26
Particulars MAR 2022 (Values in Cr)
Book Value / Share 48.66
ROE % 16.43
ROCE % 21.70
Total Debt to Total Equity 0.07
EBITDA Margin 19.36
Particulars MAR 2021 (Values in Cr)
Book Value / Share 84.87
ROE % 21.72
ROCE % 24.78
Total Debt to Total Equity 0.15
EBITDA Margin 23.45
Particulars MAR 2020 (Values in Cr)
Book Value / Share 66.02
ROE % 13.67
ROCE % 15.42
Total Debt to Total Equity 0.25
EBITDA Margin 17.08
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 36.65
Total Assets 101.61
Total Liabilities 101.61
Total Equity 85.63
Share Outstanding 12304636
Price to Book Ratio 3.10
Return on Assets (%) 14.27
Return on Capital (%) 16.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 22.24
Total Assets 88.86
Total Liabilities 88.86
Total Equity 71.23
Share Outstanding 12304636
Price to Book Ratio 2.42
Return on Assets (%) 12.75
Return on Capital (%) 15.91
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 16.20
Total Assets 78.69
Total Liabilities 78.69
Total Equity 59.87
Share Outstanding 12304636
Price to Book Ratio 3.28
Return on Assets (%) 11.70
Return on Capital (%) 15.39
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 21.16
Total Assets 76.38
Total Liabilities 76.38
Total Equity 52.21
Share Outstanding 6152318
Price to Book Ratio 1.46
Return on Assets (%) 15.20
Return on Capital (%) 19.4
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 7.37
Total Assets 60.11
Total Liabilities 60.11
Total Equity 40.61
Share Outstanding 6152318
Price to Book Ratio 0.48
Return on Assets (%) 7.92
Return on Capital (%) 10.53
Particulars MAR 2024 (Values in Cr)
Net Income 19.51
Cash from Operations 24.60
Cash from Investing -5.83
Cash from Financing 0.00
Net change in Cash 14.41
Free Cash Flow 30.68
Particulars MAR 2023 (Values in Cr)
Net Income 15.07
Cash from Operations 17.64
Cash from Investing -7.33
Cash from Financing 0.00
Net change in Cash 6.03
Free Cash Flow 25.27
Particulars MAR 2022 (Values in Cr)
Net Income 12.70
Cash from Operations 10.73
Cash from Investing -3.01
Cash from Financing -9.55
Net change in Cash -4.95
Free Cash Flow 13.94
Particulars MAR 2021 (Values in Cr)
Net Income 14.72
Cash from Operations 15.67
Cash from Investing 0.05
Cash from Financing 1.64
Net change in Cash 13.78
Free Cash Flow 20.72
Particulars MAR 2020 (Values in Cr)
Net Income 5.99
Cash from Operations 8.54
Cash from Investing -1.45
Cash from Financing 1.11
Net change in Cash 7.34
Free Cash Flow 10.10
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
GLAXOSMITHKLINE PHARMA LT 2959.45 58.70 29.97 50134.87 1924.30 / 3147.45
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 21.96 6.19 279.41 34.11 / 77.70
AMRUTAJAN HEALTH LTD 692.80 40.61 6.72 2002.93 548.05 / 861.40
ASTRAZENECA PHARMA IND LT 8665.50 129.24 31.88 21663.75 5000.00 / 9199.00
BLISS GVS PHARMA LTD 119.00 15.45 1.22 1253.91 92.25 / 184.95

PAR DRUGS AND CHEM LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
99.41 -2.67 redarrow
red-green-graph indicator
14 Bearish
2 Bullish
  • 5 Days 101.90
  • 26 Days 102.40
  • 10 Days 101.60
  • 50 Days 116.00
  • 12 Days 101.30
  • 100 Days 147.10
  • 20 Days 101.00
  • 200 Days 179.70
102.31 PIVOT

First Support

97.83

First Resistance

106.63

Second Support

93.51

Second Resistance

111.11

Third Support

89.03

Third Resistance

115.43

RSI

44.42

ADX

22.10

MACD

-1.07

Williams % R

-58.88

Commodity Channel Index (CCI)

24.23

Date

2025-01-15

Week

29427.00

Same Day

43285.00

Month

40897.00

1 Year

0.86

3 Year

0.52

Over 1 Month

14.68%

down

Over 1 Year

-63.11%

down

Over 3 Months

-46.38%

down

Over 3 Years

-14.97%

down

Over 6 Months

-66.09%

down

Over 5 Years

41.73%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

PAR DRUGS AND CHEM LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
26.62%
Promoter Holdings
73.36%
FII
0.0%
DII
0.0%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Jignesh Vallabhbhai Savani 2692440.0 (21.88%) Shareholding of Promoter and Promoter Group
Falgun Vallabhbhai Savani 2645952.0 (21.5%) Shareholding of Promoter and Promoter Group
Saritaben Vallabhbhai Savani 2520318.0 (20.48%) Shareholding of Promoter and Promoter Group
Ghanshayambhai B Savani 802284.0 (6.52%) Shareholding of Promoter and Promoter Group
Econo Trading And Investment Private Limited 219269.0 (1.78%) Public Shareholding
Savani Nayna Jignesh 189384.0 (1.54%) Shareholding of Promoter and Promoter Group
Shilpaben Falgun Savani 177372.0 (1.44%) Shareholding of Promoter and Promoter Group
Adequate Real Trade Llp 161995.0 (1.32%) Public Shareholding
Phal-jig Fine Chemicals Private Limited 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Parul Sanjay Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Savani Vallabhdas Jivabhai (huf) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sarthi Construction 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Govind Jivraj Tarpara (huf) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Ghanshayambhai Bhagvanbhai Savani (huf) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Savani Jigneshkumar Vallabhbhai (huf) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Savani Falgun Vallabhbhai (huf) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Payal Virani 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Poonam Nishant Patel 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Vasu Padariya 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Dhiraj Govindbhai Tarpara 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Govind Jivrajbhai Tarparanand Rajmoti Chemicals Industries -proprietorship Of Govind Jivraj 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Jinen Jigneshbhai Savani 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Aayush Jigneshbhai Savani 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sameer Shirish Padhye And Nshree Packaging- Proprietorship Of Sameer Padhye 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Sudha Shirish Padhye 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Shirish Laxmamrao Padhye And Nom Gases- Proprietorship Of Shirish Padhye 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rakesh Balubhai Padariya (huf) 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Mihika Falgunbhai Savani 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Savani Devansh Falgunbhai 0.0 (0.0%) Shareholding of Promoter and Promoter Group
Rita Haresh Radadiya 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

PAR DRUGS AND CHEM LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
22 Nov 2021 1.25 Interim 23 Nov 2021 Equity shares
10 Jul 2020 1.25 Final 14 Jul 2020 Equity shares
22 Nov 2019 1.25 Interim 25 Nov 2019 Equity shares
Ex-Date Ex-Bonus Ratio
28 Apr 2021 27 Apr 2021 1:1
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
22 Nov 2021 1.25 Interim 23 Nov 2021 Equity shares
10 Jul 2020 1.25 Final 14 Jul 2020 Equity shares
22 Nov 2019 1.25 Interim 25 Nov 2019 Equity shares
Ex-Date Ex-Bonus Ratio
28 Apr 2021 27 Apr 2021 1:1
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

PAR DRUGS AND CHEM LTD Share Price

Par Drugs and Chemicals Limited was originally incorporated as a Private Limited Company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat. On 26 February 1999. Subsequently, the Company was converted into a Public Limited Company and the name was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018.

The Company is primarily engaged in manufacturing of Active Pharma Ingredients and fine chemicals (API) for domestic market as well as for exports to international markets. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients.

The Company currently own and operate two manufacturing facilities at Bhavnagar and Ankleshwar in the Gujarat. It currently have three manufacturing blocks at Bhavnagar facility for different products. The Bhavnagar facility certified by food & drugs control administration. During the year 2011, the company has added two manufacturing block out of three at Chitra, Bhavnagar facility. One is dedicated facility for its main API and another one is for Fine Chemicals.

The Product portfolio presently comprises 12 APIs and 6 Fine Chemicals which are marketed domestically and exported. The Company supplies its products to approximately 16 countries, including both direct and indirect exports. The Key customers include Essential Drugs Company Limited, Taurus Chemicals (P) Limited, Pfizer Limited, United Phosphorus Limited(Samba Jammu Unit), Shiv Silica Private Limited.

The Company raised money from public through IPO by issuing 16,72,000 Equity Shares aggregating to Rs 8.53 Crore in May, 2019.

In June, 2021, the Company started a set of new production line-up i.e. one new manufacturing block, which increases production capacity within the existing product portfolio i.e. same as per existing product portfolio and market. There are four Manufacturing Blocks at Bhavnagar which are for different products having a capacity of approx 9,700 MTPA. Block 1 - APls, Block 2 - Magnesium Hydroxide, Block 3 - Fine Chemicals and Block 4 - APls/ Fine Chemicals.

Parent organization Indian Private
NSE symbol PAR
Founded 1999
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Par Drugs & Chemicals Ltd?

Answer Field

The share price of Par Drugs & Chemicals Ltd for NSE is ₹ 98.5 and for BSE is ₹ 0.00.

What is the Market Cap of Par Drugs & Chemicals Ltd?

Answer Field

The market cap of Par Drugs & Chemicals Ltd for NSE is ₹ 1,22.30 Cr. and for BSE is ₹ 0.0 Cr. as of now.

What is the 52 Week High and Low of Par Drugs & Chemicals Ltd?

Answer Field

The 52 Week High and Low of Par Drugs & Chemicals Ltd for NSE is ₹ 348.45 and ₹ 81.01 and for BSE is ₹ 0.00 and ₹ 0.00.

How to Buy Par Drugs & Chemicals Ltd share?

Answer Field

You can trade in Par Drugs & Chemicals Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Par Drugs & Chemicals Ltd?

Answer Field

The 1 year returns on the stock has been -63.11%.

What is the Current Share Price of Par Drugs & Chemicals Ltd?

Answer Field

Par Drugs & Chemicals Ltd share price is for NSE ₹ 98.5 & for BSE ₹ 0.00 as on Apr 30 2025 03:27 PM.

What is the Market Cap of Par Drugs & Chemicals Ltd Share?

Answer Field

The market cap of Par Drugs & Chemicals Ltd for NSE ₹ 1,22.30 & for BSE ₹ 0.0 as on Apr 30 2025 03:27 PM.

What is the P/E Ratio of Par Drugs & Chemicals Ltd Share?

Answer Field

As on Apr 30 2025 03:27 PM the price-to-earnings (PE) ratio for Par Drugs & Chemicals Ltd share is 7.93.

What is the PB ratio of Par Drugs & Chemicals Ltd Share?

Answer Field

As on Apr 30 2025 03:27 PM, the price-to-book (PB) ratio for Par Drugs & Chemicals Ltd share is 78.63.

How to Buy Par Drugs & Chemicals Ltd Share?

Answer Field

You can trade in Par Drugs & Chemicals Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Par Drugs & Chemicals Ltd Share on Bajaj Broking App?

Answer Field

To buy Par Drugs & Chemicals Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Par Drugs & Chemicals Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|